Semaglutide

Weight Loss

A GLP-1 receptor agonist widely studied in metabolic and weight research.

Half-life

168 h

Common dose

35 – 140 mcg

Dosing frequency

Daily

Administration

Subcutaneous

Research notes

GLP-1 agonist. Typically titrated by protocol, not weight. Start low.

This information is for educational purposes only and does not constitute medical advice.